{
  "resourceType": "PlanDefinition",
  "id": "ANCDT30",
  "url": "http://fhir.org/guides/who/anc-cds/PlanDefinition/ANCDT30",
  "identifier": [ {
    "use": "official",
    "value": "ANC.DT.30"
  } ],
  "name": "General risk reduction counselling",
  "title": "ANC.DT.30 General risk reduction counselling",
  "type": {
    "coding": [ {
      "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
      "code": "eca-rule"
    } ]
  },
  "status": "active",
  "experimental": false,
  "date": "2021-01-24T10:38:52-07:00",
  "description": "Depending on a variety of risk factors and/or gestational age, provide additional counselling accordingly",
  "action": [ {
    "title": "ANC.DT.30 General risk reduction counselling",
    "trigger": [ {
      "type": "named-event",
      "name": "ANC.B9. Conduct laboratory tests and imaging"
    } ],
    "action": [ {
      "title": "Provide counselling on Rh factor negative",
      "description": "Rh factor\" = \"Rh negative\"",
      "textEquivalent": "– Woman is at risk of alloimmunization if the baby's father is Rh positive or unknown\n– Proceed with local protocol to investigate sensitization and the need for referral \n– If non-sensitized, woman should receive anti-D prophylaxis postnatally if the baby is Rh positive",
      "documentation": [ {
        "type": "citation",
        "label": "WHO ANC recommendations (2016): C.3. Antenatal anti-D immunoglobulin administration (2)"
      } ],
      "condition": [ {
        "kind": "applicability",
        "expression": {
          "description": "Rh factor\" = \"Rh negative\"",
          "language": "text/x-pseudo"
        }
      } ]
    }, {
      "title": "Provide counselling on intrapartum antibiotic to prevent early neonatal Group B Streptococcus (GBS) infection",
      "description": "Midstream urine culture (recommended)\" = \"Positive – Group B Streptococcus (GBS)\"",
      "textEquivalent": "Pregnant women with GBS colonization should receive intrapartum antibiotic administration to prevent early neonatal GBS infection",
      "documentation": [ {
        "type": "citation",
        "label": "WHO ANC recommendations (2016): C.1: Antibiotics for asymptomatic bacteriuria (ASB) (2)"
      } ],
      "condition": [ {
        "kind": "applicability",
        "expression": {
          "description": "Midstream urine culture (recommended)\" = \"Positive – Group B Streptococcus (GBS)\"",
          "language": "text/x-pseudo"
        }
      } ]
    } ]
  } ]
}